These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 5055688)

  • 1. Preclinical pharmacologic studies on 1-nitro-9-(dimethylaminopropylamino)-acridine and its n-oxide. II. Chronic action.
    Gieldanowski J; Patkowski J; Szaga B; Teodorczyk J
    Arch Immunol Ther Exp (Warsz); 1972; 20(3):419-44. PubMed ID: 5055688
    [No Abstract]   [Full Text] [Related]  

  • 2. Preclinical pharmacologic investigations on 1-nitro-9-(dimethylaminopropylamino)-acridine and its N-oxide. I. Acute and subchronic activity.
    Gieldanowski J; Patkowski J; Szaga B; Teodorczyk J
    Arch Immunol Ther Exp (Warsz); 1972; 20(3):399-417. PubMed ID: 5055687
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacologic studies on 1-nitro-9-(5-dimethylaminopentylamino)-acridine and 1-nitro-10(3-dimethylaminopropyl)-acridone. II. Chronic action.
    Patkowski J; Kowalczyk-Bronisz SH; Szaga B; Teodorczyk J; Gieldanowski J
    Arch Immunol Ther Exp (Warsz); 1973; 21(5):797-820. PubMed ID: 4771984
    [No Abstract]   [Full Text] [Related]  

  • 4. Preclinical pharmacologic studies on 1-nitro-9-(dimethylamino)-acridine and 1-nitro-10-(dimethylaminoethyl)-9-acridone. II. Chronic action.
    Pelczarska A; KPOWALCZUK-Bronisz H; Blaszcyk B; Gieldanowski J; Patkowski J
    Arch Immunol Ther Exp (Warsz); 1974; 22(6):843-62. PubMed ID: 4451446
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacological studies on 1-nitro-9-alkyl acridine derivatives. II. Chronic action.
    Kowalczyk-Bronisz SH; Blaszczyk B; Gieldonowski J; Patkowski J; Pelczarska A
    Arch Immunol Ther Exp (Warsz); 1975; 23(3):415-34. PubMed ID: 1217966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological studies on new oncostatic acridine derivatives. II. Chronic action.
    Błaszczyk B; Giełdanowski J; Patkowski J; Kowalczyk-Bronisz SH
    Arch Immunol Ther Exp (Warsz); 1979; 27(6):765-76. PubMed ID: 549531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical pharmacologic investigations on a new group of acridine derivatives with oncostatic activity. II. Chronic action.
    Giełdanowski J; Wieczorek Z; Kowalczyk-Bronisz SH; Kowalewska D; Błaszczyk B; Skibiński G; Zimecki M
    Arch Immunol Ther Exp (Warsz); 1980; 28(5):755-76. PubMed ID: 7212982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical pharmacologic studies on 1-nitro-9-(dimethylamino)-acridine and 1-nitro-10-(dimethylaminoethyl)-9-acridone. I. Acute and subacute action.
    Pelczarska A; Kowalczyk-Bronisz SH; Blaszczyk B; Gieldanowski J; Patkowski J
    Arch Immunol Ther Exp (Warsz); 1974; 22(6):823-42. PubMed ID: 4451445
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacologic studies on 1-nitro-9-(5-dimethyl-aminopentylamino)-acridine and 1-nitro-10-(3-dimethylaminopropyl)-acridone. 1. Acute and subchronic action.
    Patkowski J; Kowalczyk-Bronisz SH; Szaga B; Teodorczyk J; Gieldanowski J
    Arch Immunol Ther Exp (Warsz); 1973; 21(5):775-95. PubMed ID: 4771983
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacological studies on new oncostatic acridine derivatives. I. Acute and subchronic action.
    Błaszczyk B; Giełdanowski J; Patkowski J; Kowalczyk-Bronisz SH
    Arch Immunol Ther Exp (Warsz); 1979; 27(6):749-63. PubMed ID: 549530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological studies on 1-nitro-9-alkyl acridine derivatives. I. Acute and subchronic action.
    Kowalczyk-Bronisz SH; Blaszczyk B; Gieldanowski J; Patkowski J; Pelczarska A
    Arch Immunol Ther Exp (Warsz); 1975; 23(3):391-413. PubMed ID: 1217965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Determination of average hematological values in the population of Forli].
    Ornigotti L
    Quad Sclavo Diagn; 1973 Jun; 9(2):698-70. PubMed ID: 4789474
    [No Abstract]   [Full Text] [Related]  

  • 13. [The effect of prolonged histone administration on peripheral blood and several other indications of the condition of experimental animals].
    Samedov ASh; Podol'skiĭ VI; Kamyshintsev MV; Chernykh VM; Ashmarin IP
    Antibiotiki; 1974 Jul; 19(7):587-93. PubMed ID: 4463891
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of immunotropic drugs on adrenocortical functions.
    Patkowski J; Gieldanowski J
    Acta Physiol Pol; 1973; 24(4):561-70. PubMed ID: 4741489
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pharmacological studies of protease, TSP-X produced by Serratia, 4. Studies on the chronic toxicity of TSP-X].
    Tamura S; Masuda M; Fukuchi K; Iijima M
    Nihon Yakurigaku Zasshi; 1968 Jul; 64(4):419-36. PubMed ID: 5751133
    [No Abstract]   [Full Text] [Related]  

  • 16. Preclinical toxicity studies on Sintamil.
    Rao RR
    Indian J Exp Biol; 1974 May; 12(3):252-6. PubMed ID: 4448482
    [No Abstract]   [Full Text] [Related]  

  • 17. [Blood pattern in white rats in the course of sexual cycle].
    Gloskowska-Moraczewska Z; Sitarska E
    Acta Haematol Pol; 1973; 4(2):117-21. PubMed ID: 4737727
    [No Abstract]   [Full Text] [Related]  

  • 18. [Contributions on tuberculosis diagnosis in horses. II. Hematologic studies].
    Richter W
    Arch Exp Veterinarmed; 1966 Jun; 20(3):477-87. PubMed ID: 6011667
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies of pharmacological activity several acridine derivatives with cytostatic and oncostatic properties.
    Gieldanowski J
    Mater Med Pol; 1976; 8(3):252-7. PubMed ID: 1034858
    [No Abstract]   [Full Text] [Related]  

  • 20. Hypoxia-selective antitumor agents. 13. Effects of acridine substitution on the hypoxia-selective cytotoxicity and metabolic reduction of the bis-bioreductive agent nitracrine N-oxide.
    Lee HH; Wilson WR; Ferry DM; van Zijl P; Pullen SM; Denny WA
    J Med Chem; 1996 Jun; 39(13):2508-17. PubMed ID: 8691448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.